Company: SPEG
Filing Date: 2025-01-21
Form Type: S-1
Source: 0001213900-25-005097
Chunk: 269

Company: Silver Pegasus Acquisition Corp.
Filing Date: 2025-01-21
Form: S-1
Chunk 269
---
 only by resolution of the board of directors. Subject to the terms of any preference shares, any or all of the directors may be removed from office at any time by an ordinary resolution, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the company. Prior to the consummation of an initial business combination, only holders of our Class B ordinary shares will have the right to vote on the appointment and removal of directors. Our board of directors may, by a vote of a majority of our directors then in office, appoint any person to be a director, either to fill a vacancy or as an additional director. Securities Eligible for Future Sale Immediately after this offering we will have 19,300,000 (or 22,775,000 if the underwriters’ over -allotmentoption is exercised in full) ordinary shares outstanding, which includes 15,000,000 public Class A ordinary shares (or 17,250,000 if the underwriters’ over -allotmentoption is exercised in full), 3,750,000 Class B ordinary shares (or 4,312,500 Class B Shares if the underwriters’ over -allotmentoption is exercised in full), and 550,000 Class A ordinary shares from the sale of private placement units (or 606,250 if the over -allotmentoption is exercised). Of these shares, the Class A ordinary shares sold in this offering (15,000,000 Class A ordinary shares if the underwriters’ over -allotmentoption is not exercised and 17,250,000 shares if the underwriters’ over -allotmentoption is exercised in full) will be freely tradable without restriction or further registration under the Securities Act, except for any Class A ordinary shares purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of the outstanding founder shares (3,750,000 founder shares if the underwriters’ over -allotmentoption is not exercised and 4,312,500 founder shares if the underwriters’ over -allotmentoption is exercised in full) and all of the outstanding private placement units (550,000 private placement units or 606,250 private placement units if the underwriters’ over -allotmentoption is exercised) will be restricted securities under Rule 144, in that they